|
Last Updated: Nov 17th, 2006 - 22:35:04 |
Latest Research
:
Anaethesia
Near infrared laser device can measure brain oxygen levels
A new device that uses near-infrared light to non-invasively monitor the oxygenation of the brain during surgery appears to be a promising alternative to the more invasive techniques currently in use, according to a new study by Duke University Medical Center anesthesiologists. The researchers said their findings offer the potential for accurate and reliable monitoring of brain oxygenation during cardiac surgeries, to more effectively protect the brain against reduced oxygen levels, or anoxia, which is known to cause cognitive impairment in some surgical patients. During some surgeries anesthesiologists measure venous oxygenation by periodically removing blood samples from catheters inserted in major blood vessels in the neck and then analyze the samples by co-oximetry. Also, anesthesiologists frequently use a pulse oximeter, attached to the patient's finger, to measure arterial blood oxygenation. However, since these measurements are taken on blood outside the brain, physicians can only estimate the level of cerebral oxygenation.
Oct 25, 2005, 05:26
Latest Research
:
Anaethesia
:
Resuscitation
Hospital characteristics play a role in use of do-not-resuscitate orders
Hospital characteristics, including size, non-profit status and affiliation with a university, appear to be associated with use of do-not-resuscitate orders (DNR) in California, independent of the patient's characteristics, according to a study in the August 8/22 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
Aug 10, 2005, 13:13
Latest Research
:
Anaethesia
Latest Data on Novel Short-acting Sedatives
CeNeS Pharmaceuticals plc (AIM: CEN) (�CeNeS� or �the Company�) today announced that recent presentations at two anaesthesia congresses included new data on two of its product programmes: morphine-6-glucuronide (M6G) for post�operative pain and CeNeS� short-acting sedative programme.
Jun 2, 2005, 10:31
Latest Research
:
Anaethesia
Org 25969 - the First Selective Relaxant Binding Agent for Neuromuscular Block Reversal Enters Phase 3
Organon and the US Food and Drug Administration (FDA) have reached agreement on the clinical development plan that will allow Org 25969 - the first selective relaxant binding agent to reverse neuromuscular block - to enter Phase 3 studies. The decision follows an End of Phase 2 meeting earlier this month, during which the FDA accepted the plans with only minor requests for additional data.
May 24, 2005, 10:06
Latest Research
:
Anaethesia
Dangerous reduction in Oxygen levels during Air Travel
More than half of air travellers find that their oxygen saturation drops to a level at which many hospital patients would be prescribed extra oxygen, according to a paper in the May issue of Anaesthesia.
Apr 25, 2005, 19:36
|
